A year and a half after US Food and Drug Administration (FDA) officials called for including adolescent patients in adult oncology clinical trials, the agency has issued draft guidance providing recommendations to industry on how to do so.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,